JHS Svendgaard Laboratories Limited (JHS.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-781.8%

-₹54.54

vs ₹8.00 price

Levered DCF

-₹57.77

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

—

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-29.77×	-4.95×	-32.6×	-6.95×	-32.62×	100×	-23.59×	-259.09×
P/B	0.33×	0.57×	0.78×	0.7×	0.71×	0.65×	0.26×	0.98×
P/S	0.56×	1.06×	1.89×	1.45×	1.55×	1.23×	0.33×	1.41×
EV / EBITDA	11.27×	-24.41×	37.98×	-6.09×	15.57×	11.52×	11.21×	29.61×
Gross margin	17.4%	33.6%	29.2%	19.7%	23.6%	26.4%	4.6%	25.5%
Operating margin	-4.8%	-13.0%	-9.0%	-17.4%	-8.6%	3.7%	-2.0%	-1.4%
Net margin	-1.9%	-21.5%	-5.8%	-20.8%	-4.7%	1.2%	-1.4%	-0.6%
Current ratio	1.95×	2.18×	1.87×	2.31×	4.18×	5.23×	2.69×	2.63×
Debt / equity	0.09×	0.04×	0.03×	0.09×	0.03×	0.04×	0.05×	0.04×
Interest coverage	-5.68×	-21.17×	-14.75×	-26.71×	-5.29×	2.96×	-1.42×	-1.66×
Dividend yield	0.0%	0.0%	21.5%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	-700.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-1.1%	-11.4%	-2.4%	-10.1%	-2.2%	0.6%	-1.1%	-0.4%
Return on invested capital	-2.1%	-6.6%	-3.5%	-5.8%	149.9%	1.8%	-1.2%	-0.7%
Return on assets	-0.9%	-9.8%	-2.1%	-7.7%	-1.8%	0.5%	-0.8%	-0.3%
Free cash flow yield	-26.0%	-16.1%	-30.3%	7.4%	-12.0%	3.0%	-7.9%	-15.2%
Earnings yield	-3.4%	-20.2%	-3.1%	-14.4%	-3.1%	1.0%	-4.3%	-0.4%
Enterprise value	₹683.3M	₹974.3M	₹1.3B	₹997.8M	₹1.3B	₹1.1B	₹545.9M	₹1.8B
Net debt / EBITDA	1.83×	0.07×	-1.18×	1.33×	0.1×	-1.46×	1.77×	1.05×
Cash conversion cycle (days)	48	43	98	93	68	234	191	103